NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. Photo: Indranil Bhoumik/MintNew Delhi: National Pharmaceutical Pricing Authority (NPPA) on Wednesday said it has fixed the retail price for 30 drug formulations, including those used for treatment of diabetes, bacterial infections and high blood pressure. NPPA has also revised the prices of three formulations, including that of anti cancer drug—Gemcitabine. “NPPA has fixed/revised ceiling prices/retail prices of 33 formulations under Drugs (Prices Control) Order, 2013,” NPPA said in a notification. It is also entrusted with the task of recovering amounts overcharged by manufacturers for the controlled drugs from the consumers.

Source: Mint January 17, 2018 14:48 UTC